iifl-logo-icon 1

ERIS Lifesciences Ltd Annually Results

1,248.8
(-1.29%)
Feb 14, 2025|03:41:52 PM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Financials

Particulars (Rupees in Crores.)Mar-2024Mar-2023Mar-2022Mar-2021Mar-2020

Gross Sales

1,991.3

1,661.82

1,326.17

1,192.64

1,058.18

Excise Duty

0

0

0

0

0

Net Sales

1,991.3

1,661.82

1,326.17

1,192.64

1,058.18

Other Operating Income

17.85

23.33

20.88

19.22

15.88

Other Income

23.82

11.15

26.09

8.71

15.4

Total Income

2,032.97

1,696.3

1,373.14

1,220.57

1,089.46

Total Expenditure

1,334.32

1,148.4

862.09

781.29

705.69

PBIDT

698.65

547.9

511.05

439.28

383.77

Interest

84.8

26.17

4.15

1.8

2.16

PBDT

613.85

521.73

506.9

437.48

381.61

Depreciation

182.61

117.09

64.71

42.99

50.26

Minority Interest Before NP

0

0

0

0

0

Tax

82.22

74.66

81.82

69.4

60.7

Deferred Tax

-48.03

-44.18

-45.42

-30.04

-25.85

Reported Profit After Tax

397.05

374.16

405.79

355.14

296.51

Minority Interest After NP

5.07

-8

-0.32

0

0.01

Net Profit after Minority Interest

391.98

382.16

406.11

355.14

296.5

Extra-ordinary Items

0

0

0

0

0

Adjusted Profit After Extra-ordinary item

391.98

382.16

406.11

355.14

296.5

EPS (Unit Curr.)

28.82

28.1

29.89

26.16

21.61

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

735

601

550

287

Equity

13.6

13.6

13.59

13.58

13.58

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

35.08

32.96

38.53

36.83

36.26

PBDTM(%)

30.82

31.39

38.22

36.68

36.06

PATM(%)

19.93

22.51

30.59

29.77

28.02

ERIS Lifescience: Related NEWS

ChrysCapital pares stake in Eris Lifesciences; stock slips ~3%
23 Aug 2024|12:30 PM

The shares were sold at an average price of ₹1,201 each, totalling ₹1,187.41 Crore. Infinity Partners acquired these shares.

Read More
Top 10 stocks for today - 16th July, 2024
16 Jul 2024|08:47 AM

Here are some of the stocks that may see significant price movement today: Hindustan Unilever, Birla Estates, Lupin, etc.

Read More

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Securities Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

plus
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.